Shopping Cart
Remove All
Your shopping cart is currently empty
Antitumor Agent-92, an Icaritin derivative, induces G0/G1 phase cell cycle arrest and promotes apoptosis. This compound shows promise for hepatocellular carcinoma (HCC) research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | Antitumor Agent-92, an Icaritin derivative, induces G0/G1 phase cell cycle arrest and promotes apoptosis. This compound shows promise for hepatocellular carcinoma (HCC) research [1]. |
| In vitro | Antitumor agent-92 (Compound 11c; 2-8 μM; 48 hours) induces apoptosis in HepG2 and SMMC-7721 cells, with increased effects at higher concentrations [1]. The compound also promotes G0/G1 phase arrest in these cells [1]. Additionally, Antitumor agent-92 upregulates P21 and downregulates Cdc2 p34 and CDK4 [1]. |
| Molecular Weight | 611.68 |
| Formula | C33H41NO10 |
| Cas No. | 2922842-01-9 |
| Smiles | #N/A |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.